Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myeloproliferative Disorders × Topotecan × 90 days × Clear all

Sponsor

Conditions

Small Cell Lung Carcinoma 8 Ovarian Neoplasms 5 Neuroblastoma 5 Uterine Cervical Neoplasms 3 Neoplasms 3 Ganglioneuroblastoma 3 Sarcoma, Ewing 2 Fallopian Tube Neoplasms 2 Brain Neoplasms 2 Wilms Tumor 1 Thrombocythemia, Essential 1 Rhabdoid Tumor 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pleuropulmonary blastoma 1 Osteosarcoma 1 Myelodysplastic-Myeloproliferative Diseases 1 Medulloblastoma 1 Lymphoma, Follicular 1 Localized Extraskeletal Ewing Sarcoma 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Glioma 1 Carcinoma, Ovarian Epithelial 1

Interventions

fludarabine 8 Specimen Handling 8 Biopsy 8 venetoclax 6 Azacitidine 6 Whole-Body Irradiation 5 Busulfan 5 ruxolitinib 4 decitabine and cedazuridine drug combination 4 Cyclophosphamide 4 fludarabine phosphate 3 Tacrolimus 3 Mycophenolic Acid 3 Injections 3 Cytarabine 3 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3 nilotinib 2 asciminib 2 Therapeutics 2 Stem Cell Transplantation 2 Peripheral Blood Stem Cell Transplantation 2 Melphalan 2 Liposomes 2 Granulocyte Colony-Stimulating Factor 2 Decitabine 2 Daunorubicin 2 Cyclosporins 2 CPX-351 2 Blood Specimen Collection 2 ponatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡